CAREDIESSE

CAREDIESSE 10 MG/G SHAMPOO 2 LDPE BOTTLE 60 ML

CAREDIESSE 10 MG/G SHAMPOO 2 LDPE BOTTLE 60 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
Carediesse
ciclopirox


What is it and what is it for?
What is Carediesse?
Carediesse contains an active ingredient called “ciclopirox”, an antifungal substance (which kills mold and yeast).

What is Carediesse used for?
Carediesse is used to treat a scalp disorder called seborrheic dermatitis. This condition occurs when the scalp becomes irritated and causes flaking, burning, and itching.

How Carediesse works
Carediesse works by killing yeasts and molds in the upper layers of the scalp. These yeasts and molds are one of the main causes of seborrheic dermatitis.


What you need to know before taking the medicine
Do not use Carediesse:
- If you are allergic to the active substance ciclopirox, cicloprix olamine, or any of the other ingredients of Carediesse (listed in section 6). If you are not sure, talk to your doctor or pharmacist before using Carediesse.


Warnings and precautions
Talk to your doctor or pharmacist before using Carediesse.
If Carediesse accidentally gets into your eyes, rinse them thoroughly with water.
If you accidentally swallow Carediesse, contact your doctor or pharmacist immediately.
You may notice changes in hair color, especially if your hair is damaged by chemicals such as hair dye or if you have white or gray hair.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur with this medicine.

Uncommon (affect less than 1 in 100 people)
• Skin reactions on the scalp – including skin irritation or eczema (inflamed, itchy, red, and often blistered skin that oozes fluid and forms crusts) or discomfort such as burning or itching.
• Hair problems – such as mild hair loss, discoloration, dullness, heaviness or mild dryness of the hair.

Rare (affect less than 1 in 1000 people)
• Redness of the skin where the shampoo comes into contact with the skin (allergic contact dermatitis).

Stop using Carediesse and contact your doctor if you experience skin or scalp reactions such as irritation or sensitivity (allergic reactions) after prolonged use of the medicine. Your doctor may decide to start you on a different treatment.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

CAREDIESSE

CAREDIESSE 10 MG/G SHAMPOO 2 LDPE BOTTLE 60 ML

CAREDIESSE 10 MG/G SHAMPOO 2 LDPE BOTTLE 60 ML

MINSAN code: 037474032
Previous price: €19,53
Regular price €19,50
Regular price €0,00 Sale price €19,50
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.